These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23956952)

  • 21. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.
    Luo JC; Hwang SJ; Wu JC; Li CP; Hsiao LT; Lai CR; Chiang JH; Lui WY; Chang FY; Lee SD
    Cancer; 1999 Sep; 86(5):799-804. PubMed ID: 10463978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth.
    Carr BI; Guerra V; Donghia R; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1215-1219. PubMed ID: 33006073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does hepatic vein outflow obstruction contribute to the pathogenesis of hepatocellular carcinoma?
    Bayraktar Y; Egesel T; Sağlam F; Balkanci F; Van Thiel DH
    J Clin Gastroenterol; 1998 Jul; 27(1):67-71. PubMed ID: 9706774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
    Carr BI; Guerra V; Donghia R; Farinati F; Giannini EG; Muratori L; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Sacco R; Celsa C; Campani C; Mega A; Guarino M; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Biasini E; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Brunetto MR; Trevisani F
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 26. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Presence of Portal Vein Thrombosis Alters the Classic Enhancement Associated with Diagnosis of Hepatocellular Carcinoma.
    Umar NK; Badshah MB; Sandrasegaran K; Ghabril M; Agarwal S; Tann M; Lacerda M; Kwo PY
    Dig Dis Sci; 2015 Jul; 60(7):2196-200. PubMed ID: 25777258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
    Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
    Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.
    Carr BI; Pancoska P; Branch RA
    Hepatol Int; 2009 Dec; 4(1):396-405. PubMed ID: 20305756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the Concept of a Common Typical Time of Disease Duration for Hepatocellular Carcinoma Patients Using the Fisher Information Processing of Tumor Imaging Results Combined With Network Phenotyping Strategy Quantification of Individual Patient Clinical Profile Patterns.
    Pančoška P; Skála L; Nešetřil J; Carr BI
    Semin Oncol; 2015 Aug; 42(4):672-8. PubMed ID: 26320070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.
    Chen JS; Wang Q; Chen XL; Huang XH; Liang LJ; Lei J; Huang JQ; Li DM; Cheng ZX
    J Surg Res; 2012 Jun; 175(2):243-50. PubMed ID: 21601221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Features of massive hepatocellular carcinomas.
    Carr BI; Guerra V
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):101-8. PubMed ID: 23863262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
    Carr BI; Giannelli G; Guerra V; Giannini EG; Farinati F; Rapaccini GL; Marco MD; Zoli M; Caturelli E; Masotto A; Virdone R; Sacco R; Trevisani F
    Int J Biol Markers; 2018 Nov; 33(4):423-431. PubMed ID: 29874983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic arterial blood flow in large hepatocellular carcinoma with or without portal vein thrombosis: assessment by transcutaneous duplex Doppler sonography.
    Săftoiu A; Ciurea T; Gorunescu F
    Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):167-76. PubMed ID: 11981341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of α-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosis.
    Taura N; Fukuda S; Ichikawa T; Miyaaki H; Shibata H; Honda T; Yamaguchi T; Kubota Y; Uchida S; Kamo Y; Yoshimura E; Isomoto H; Matsumoto T; Takeshima F; Tsutsumi T; Tsuruta S; Nakao K
    Exp Ther Med; 2012 Dec; 4(6):972-976. PubMed ID: 23226758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience.
    Patidar Y; ; Mukund A; Sarin SK
    Indian J Radiol Imaging; 2021 Apr; 31(2):270-276. PubMed ID: 34556907
    [No Abstract]   [Full Text] [Related]  

  • 38. Validation of a Liver Index and Its Significance for HCC Aggressiveness.
    Carr BI; Guerra V
    J Gastrointest Cancer; 2017 Sep; 48(3):262-266. PubMed ID: 28631027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion.
    Kokudo T; Hasegawa K; Matsuyama Y; Takayama T; Izumi N; Kadoya M; Kudo M; Ku Y; Sakamoto M; Nakashima O; Kaneko S; Kokudo N;
    J Hepatol; 2016 Nov; 65(5):938-943. PubMed ID: 27266618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Jeong Y; Yoon SM; Han S; Shim JH; Kim KM; Lim YS; Lee HC; Kim SY; Park JH; Lee SW; Ahn SD; Choi EK; Kim JH
    PLoS One; 2015; 10(8):e0135298. PubMed ID: 26252472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.